Predicting Clinical Deterioration in Pediatric Hematology-Oncology Patients: PEWS Scales-A Scoping Review

Simona Calza1, Matilde Gabrieli1, Stefano Parodi2

  • 1Health Professionals Department, IRCCS Istituto Giannina Gaslini, Genoa, Italy.

Insights

Pediatric Early Warning Scores (PEWS) effectively identify clinical deterioration in pediatric cancer patients. These scores predict unplanned intensive care unit transfers, aiding timely interventions for better outcomes.

Area of Science:

  • Pediatric Oncology
  • Critical Care Medicine
  • Clinical Informatics

Background:

  • Pediatric tumors present significant risks, necessitating early detection of clinical deterioration.
  • Pediatric Early Warning Scores (PEWS) are vital tools for timely intervention and improved patient prognosis.
  • Evaluating PEWS accuracy in hemato-oncological patients is crucial for optimizing care.

Purpose of the Study:

  • To assess the predictive accuracy of major PEWS in pediatric hemato-oncological patients.
  • To determine the effectiveness of PEWS in early recognition of clinical deterioration.
  • To evaluate PEWS's ability to predict unplanned pediatric intensive care unit (PICU) transfers.

Main Methods:

  • A scoping review of studies published between 2013 and 2023 was conducted.
  • Searches included PubMed, CINAHL, Scopus, and Web of Science for relevant English-language studies.
  • Seven studies evaluating PEWS impact on clinical deterioration and PICU transfers were included.

Main Results:

  • Several PEWS, including Bedside PEWS, CHEWS, and Modified Brighton PEWS, demonstrated high predictive accuracy (AUCs 0.91-0.95).
  • Elevated PEWS scores within 24 hours predicted the need for unplanned PICU transfers.
  • The reviewed PEWS showed good ability in detecting clinical deterioration.

Conclusions:

  • PEWS are essential for early identification of clinical deterioration in pediatric hemato-oncology.
  • Current PEWS demonstrate promising predictive capabilities for critical events and PICU transfers.
  • Further large-scale, prospective research is needed to validate and refine PEWS in diverse pediatric oncology populations.